CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
130.00
-0.67 (-0.52%)
Oct 9, 2025, 11:07 AM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $65.57 billion as of October 9, 2025. Its market cap has decreased by -31.39% in one year.
Market Cap
65.57B
Enterprise Value
76.97B
Revenue
15.56B
Ranking
n/a
PE Ratio
21.84
Stock Price
$130.00
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 65.57B, an increase of 28,387.35%. That is a compound annual growth rate of 19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 65.91B | -21.89% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |